X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2059) 2059
Publication (117) 117
Magazine Article (6) 6
Book Review (3) 3
Data Set (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (1296) 1296
humans (1055) 1055
animals (1013) 1013
glyburide - pharmacology (909) 909
female (894) 894
glyburide - administration & dosage (659) 659
rats (619) 619
glibenclamide (609) 609
glyburide - therapeutic use (552) 552
index medicus (522) 522
pharmacology & pharmacy (507) 507
middle aged (487) 487
diabetes mellitus, type 2 - drug therapy (481) 481
hypoglycemic agents - administration & dosage (458) 458
adult (415) 415
hypoglycemic agents - therapeutic use (408) 408
blood glucose - metabolism (364) 364
aged (362) 362
hypoglycemic agents - pharmacology (356) 356
glyburide (330) 330
administration, oral (325) 325
endocrinology & metabolism (285) 285
dose-response relationship, drug (283) 283
rats, wistar (280) 280
insulin (265) 265
insulin - blood (261) 261
diabetes (232) 232
diabetes mellitus, type 2 - blood (210) 210
blood glucose - analysis (208) 208
glyburide - adverse effects (191) 191
mice (191) 191
blood glucose - drug effects (188) 188
hypoglycemic agents - adverse effects (184) 184
time factors (184) 184
potassium channels - drug effects (183) 183
type 2 diabetes (176) 176
metformin (174) 174
insulin - metabolism (172) 172
drug therapy, combination (171) 171
diabetes mellitus, experimental - drug therapy (165) 165
glucose (158) 158
mellitus (158) 158
insulin - therapeutic use (154) 154
diabetes mellitus - drug therapy (149) 149
in vitro techniques (141) 141
potassium channels (141) 141
insulin secretion (138) 138
rats, sprague-dawley (135) 135
insulin - administration & dosage (133) 133
glyburide - pharmacokinetics (129) 129
pregnancy (127) 127
metformin - therapeutic use (124) 124
treatment outcome (124) 124
diabetes mellitus (120) 120
potassium channels - physiology (120) 120
drug interactions (118) 118
metformin - administration & dosage (118) 118
dogs (117) 117
sulfonylurea compounds - administration & dosage (116) 116
hypoglycemia - chemically induced (113) 113
sulfonylurea compounds - therapeutic use (109) 109
glucose tolerance test (106) 106
hypoglycemic agents - pharmacokinetics (106) 106
vasodilator agents - pharmacology (106) 106
blood pressure - drug effects (105) 105
research (105) 105
double-blind method (104) 104
drug administration schedule (102) 102
physiology (102) 102
nitric-oxide (101) 101
care and treatment (100) 100
potassium channel blockers - pharmacology (100) 100
sulfonylurea (96) 96
cardiac & cardiovascular systems (95) 95
hypoglycemia (94) 94
pharmacokinetics (94) 94
potassium channels - metabolism (94) 94
drug therapy (92) 92
glycated hemoglobin a - analysis (91) 91
peripheral vascular disease (91) 91
plant extracts - pharmacology (91) 91
therapy (91) 91
chemistry, medicinal (90) 90
analysis (88) 88
medicine, general & internal (87) 87
diabetes mellitus, experimental - blood (84) 84
cromakalim (82) 82
sulfonylureas (81) 81
glycated hemoglobin a - metabolism (80) 80
hypoglycemic agents (80) 80
c-peptide - blood (79) 79
k+ channels (79) 79
diabetes, gestational - drug therapy (78) 78
glycemic control (78) 78
disease models, animal (77) 77
risk factors (77) 77
sulfonylurea compounds - pharmacology (77) 77
dosage and administration (76) 76
health aspects (76) 76
smooth-muscle (76) 76
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1876) 1876
German (75) 75
Russian (25) 25
Italian (22) 22
French (14) 14
Spanish (14) 14
Japanese (10) 10
Chinese (7) 7
Polish (5) 5
Dutch (4) 4
Swedish (4) 4
Bulgarian (3) 3
Hebrew (3) 3
Croatian (1) 1
Hungarian (1) 1
Portuguese (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Plant Foods for Human Nutrition, ISSN 0921-9668, 9/2014, Volume 69, Issue 3, pp. 241 - 247
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 05/2016, Volume 99, Issue 5, pp. 538 - 547
Drug–drug interactions causing severe hypoglycemia due to antidiabetic drugs is a major clinical and public health problem. We assessed whether sulfonylurea... 
Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hypoglycemia - epidemiology | Glipizide - administration & dosage | Humans | Middle Aged | Glipizide - adverse effects | Male | Fenofibrate - adverse effects | Incidence | Drug Interactions | Hypoglycemic Agents - administration & dosage | Female | Retrospective Studies | Sulfonylurea Compounds - administration & dosage | Glyburide - administration & dosage | Hypoglycemia - chemically induced | Glyburide - adverse effects | Severity of Illness Index | Hypolipidemic Agents - adverse effects | Fenofibrate - administration & dosage | Sulfonylurea Compounds - adverse effects | Algorithms | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hypolipidemic Agents - administration & dosage | Aged | Hypoglycemic Agents - adverse effects | Cohort Studies | GEMFIBROZIL | GLYCEMIC CONTROL | CHEMISTRY, MEDICINAL | PROPENSITY SCORE | GLUCOSE-METABOLISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | PRAVASTATIN | TYPE-2 DIABETES-MELLITUS | INSULIN SENSITIVITY | GLYBURIDE | CORONARY-ARTERY-DISEASE | DRUG-INDUCED HYPOGLYCEMIA | Care and treatment | Dosage and administration | Management | Hypoglycemia | Hypoglycemic sulfonylureas | Sulfonylurea compounds | Risk factors | Public health | drug interactions | fibric acids | sulfonylurea compounds | hypoglycemia | cohort studies | hydroxymethylglutaryl-CoA reductase inhibitors | Medicaid | pharmacoepidemiology | propensity score
Journal Article
Diabetes Care, ISSN 0149-5992, 08/2016, Volume 39, Issue 8, pp. 1329 - 1337
OBJECTIVETo analyze the impact of adding saxagliptin versus placebo on the risk for hypoglycemia and to identify predictors of any and major hypoglycemia in... 
DIABETES-MELLITUS | INSULIN | METAANALYSIS | HYPERGLYCEMIA | ENDOCRINOLOGY & METABOLISM | VASCULAR OUTCOMES | RISK | COMPLICATIONS | BLOOD-GLUCOSE CONTROL | TYPE-2 | BASE-LINE CHARACTERISTICS | Insulin, Short-Acting - adverse effects | Multivariate Analysis | Follow-Up Studies | Insulin, Short-Acting - administration & dosage | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Renal Insufficiency - prevention & control | Hypoglycemia - prevention & control | Renal Insufficiency - chemically induced | Hypoglycemic Agents - administration & dosage | Female | Sulfonylurea Compounds - administration & dosage | Glyburide - administration & dosage | Adamantane - administration & dosage | Hypoglycemia - chemically induced | Glyburide - adverse effects | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Body Mass Index | Dipeptides - adverse effects | Risk Factors | Proportional Hazards Models | Insulin - administration & dosage | Sulfonylurea Compounds - adverse effects | Dipeptides - administration & dosage | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Type 2 diabetes | Physicians | Practice | Dosage and administration | Research | Hypoglycemia | Patients | Health aspects | Risk factors | Saxagliptin
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0134476
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 05/2016, Volume 102, pp. 41 - 50
Journal Article
Diabetes Research and Clinical Practice, ISSN 0168-8227, 2014, Volume 107, Issue 1, pp. 104 - 112
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 8/2011, Volume 37, Issue 8, pp. 1368 - 1377
The calcium-sensitizing drug levosimendan increases myocardial contractility and, by activating K+-channels, dilates pulmonary vessels. In the acute setting,... 
Vascular remodeling | Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Levosimendan | Intensive / Critical Care Medicine | Pulmonary arterial hypertension | Anesthesiology | Potassium channel | VASODILATING MECHANISMS | POTASSIUM CHANNELS | NITRIC-OXIDE SYNTHASE | K-ATP CHANNELS | HEART-FAILURE | MUSCLE-CELL PROLIFERATION | CARDIAC-MUSCLE | SMOOTH-MUSCLE | ARTERIAL-HYPERTENSION | ENDOTHELIAL-CELLS | CRITICAL CARE MEDICINE | Myocardial Contraction - drug effects | Pyridazines - pharmacology | Hypertension, Pulmonary - chemically induced | Nicorandil - pharmacology | Glyburide - pharmacology | Hypoglycemic Agents - administration & dosage | Pyridazines - administration & dosage | Hypertension, Pulmonary - drug therapy | Glyburide - administration & dosage | Disease Models, Animal | Vasodilator Agents - pharmacology | Hydrazones - administration & dosage | Rats | Cardiotonic Agents - pharmacology | Nicorandil - administration & dosage | Potassium Channels - drug effects | Rats, Sprague-Dawley | Hydrazones - pharmacology | Hypoglycemic Agents - pharmacology | Animals | Cardiotonic Agents - administration & dosage | Pulmonary Circulation - drug effects | Airway Remodeling - drug effects | Vasodilator Agents - administration & dosage | Germany | Complications and side effects | Patient outcomes | Physiological aspects | Respiratory agents | Dosage and administration | Potassium channels | Research | Drug therapy | Pulmonary hypertension
Journal Article